TVMDL is experiencing phone issues at the Canyon location. We appreciate your patience as we work to resolve these issues!
FY27 Proposed Fee Changes: TVMDL is proposing fee changes for Fiscal Year 2027 and will accept public comment until August 26. View the list of proposed changes on the Proposed Fee Change page and learn how to submit public comment.
Detection of antibodies to Brucella canis, the causative agent of canine brucellosis, by indirect fluorescent antibody test; samples tested at 1:50, 1:100, and 1:200 dilutions.
Detection of antibodies to Brucella canis, the causative agent of canine brucellosis. The Slide Agglutination Test/AGID is only available as the initial screening test for export samples. All non-export samples will be screened with the canine Brucella multiplex assay; samples with non-negative results will undergo confirmatory testing with the Slide Agglutination Test/AGID tests.
Detection of infectious agents (i.e. Hepatozoon spp., bacteria, spirochetes) and neoplastic cells (i.e. mast cells) by microscopic evaluation of the buffy coat.
Measurement of c-reactive protein (CRP) in dogs. This test is useful to confirm the presence of underlying inflammation (particularly in the absence of other clinical or laboratory indicators of inflammation) and to monitor response to therapy.